Previsioni

Non sono disponibili dati degli analisti per questa azienda.

Notizie Vai al feed delle notizie

Carasent reports improved quarterly loss and 17.9% revenue gain

Carasent reported a loss of SEK 0.04 per share for the quarter ended June 30, 2026, after a loss of SEK 0.080 per share in the year-ago quarter. Revenue rose to SEK 97.7 million, an increase of 17.91% from SEK 82.9 million a year earlier. » Altro su finanzen.net
Carasent to release quarterly results on 10 July 2026

Carasent will publish results for the quarter ended 30 June 2026 on 10 July 2026. Three analysts on average expect earnings of 0.023 SEK per share (previous year: -0.080 SEK) and revenue of SEK 94.2 million, up about 13.7% from SEK 82.9 million in the year‑ago quarter. For the current fiscal year three analysts forecast on average 0.453 SEK earnings per share and annual revenue of SEK 410.3 million (previous year: SEK 343.8 million). » Altro su finanzen.net
Carasent expects quarterly results on 10 July 2026 with positive revenue growth

Carasent will release results for the quarter ending 30 June 2026 on 10 July 2026. Three analysts on average forecast earnings per share of 0.023 SEK (prior year -0.080 SEK) and revenue growth of 13.67 percent to 94.2 million SEK. For the current fiscal year, consensus estimates are 0.453 SEK per share and revenue of 410.3 million SEK, compared with 0.500 SEK and 343.8 million SEK in the prior year. » Altro su finanzen.net

Dividendi storici Dividendi

Tutte le metriche sui dividendi Tutte le metriche

Nel 2023, Carasent ha già distribuito 0,16 € di dividendi. L'ultimo pagamento è avvenuto a novembre 2023.

Dati finanziari dell'azienda

Nell'ultimo trimestre, Carasent ha registrato ricavi pari a 8,82 Mln € e un utile netto di -249,33K €

(EUR)	giu 2026	YoY
Ricavi	8,82 Mln	18,54%
Utile lordo	7,34 Mln	16,43%
Utile netto	-249,33K	49,54%
EBITDA	1,33 Mln	23,17%

Dati fondamentali

Metrica	Valore
Capitalizzazione di mercato	161,15 Mln €
Numero di azioni	66,85 Mln
Massimo/minimo a 52 settimane	2,66 € - 1,96 €
Dividendi	No
Beta	0,37
Rapporto P/E	42,97
Rapporto PEG	0,07
Rapporto P/B	2,49
Rapporto P/S	4,91

Profilo aziendale

Carasent AB (publ) bietet Cloud-basierte Lösungen für elektronische Gesundheitsakten (EHR) und Plattformdienste für das Gesundheitswesen in den nordischen Ländern und Deutschland. Das Unternehmen bietet die Lösungen Webdoc, Webdoc X, Metodika, Ad Curis, Ad Opus und Data-AL an. Darüber hinaus bietet es die Dienste Medrave, Vårdrummet, Ad Voca und HPI Plustoo sowie ein Ökosystem von Plattformdiensten, einschließlich Lösungen für Patientenkommunikation und Business Intelligence. Das Unternehmen wurde 1997 gegründet und hat seinen Hauptsitz in Göteborg, Schweden.